Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in MBRX — Moleculin Biotech, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to MBRX Full portfolio

Position in MBRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$558
+$447 QoQ
Shares Held
200
+19900.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 18 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. MBRX ranks #374 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in MBRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $558 200
2024-03-31 $111 19
2023-12-31 $196 229
2023-09-30 $306 717
2023-06-30 $123 214
2023-03-31 $190 198
2022-12-31 $550 520
2022-09-30 $201 190
2022-06-30 $276 191
2022-03-31 $7,433 4,176
2021-12-31 $7,765 4,175
2021-09-30 $525 175
2021-06-30 $623 170
2021-03-31 $697 171
2020-12-31 $301 378
2020-09-30 $67,086 82,518
2020-06-30 $75,488 77,986
2020-03-31 $554 910